Pr Laurent Greillier

Specialty

Oncologist, lung expert

Title

Head of department

Hospital

AP-HM Hôpital Nord (Marseille)

Latest articles

• Outcomes of long-term responders to immunotherapy in the treatment of advanced non-small cell lung cancer (NSCLC). A retrospective regional study. (Nov 1, 2026)
• Pembrolizumab with or without platinum-based chemotherapy as first-line treatment in advanced NSCLC expressing PD-L1 ≥50%: The PERSEE randomized phase III trial (GFPC 01-2020). (Oct 25, 2026)
• Using the Geriatric Core Dataset (G-CODE) to predict mortality in older patients with cancer: development and external validation. (Oct 12, 2026)
• First round of lung cancer screening among patients with atheromatous cardiovascular disease exposed to tobacco: a prospective cohort study. (Sep 25, 2026)
• Tolerance and Efficacy of Targeted Therapies After Immunotherapy for Advanced Non-Small Cell Lung Cancers Harboring Oncogenic Alterations: The GFPC-TOXIMAD Study. (Aug 27, 2026)